Invention Grant
- Patent Title: Alpha-synuclein kinase
- Patent Title (中): α-突触核蛋白激酶
-
Application No.: US12702201Application Date: 2010-02-08
-
Publication No.: US08148089B2Publication Date: 2012-04-03
- Inventor: John P. Anderson , Kelly Banducci , Guriqbal S. Basi , David Chereau , Tamie J. Chilcote , Normand L. Frigon, Jr. , Jason Goldstein , Irene Griswold
- Applicant: John P. Anderson , Kelly Banducci , Guriqbal S. Basi , David Chereau , Tamie J. Chilcote , Normand L. Frigon, Jr. , Jason Goldstein , Irene Griswold
- Applicant Address: IE Dublin
- Assignee: Elan Pharma International Limited
- Current Assignee: Elan Pharma International Limited
- Current Assignee Address: IE Dublin
- Agency: Alston & Bird LLP
- Main IPC: G01N33/53
- IPC: G01N33/53
Abstract:
The invention provides agents and methods for treatment of diseases associated with Lewy body diseases (LBDs) in the brain of a patient. Preferred agents include inhibitors of PLK2 kinase.
Public/Granted literature
- US20100143946A1 ALPHA-SYNUCLEIN KINASE Public/Granted day:2010-06-10
Information query
IPC分类:
